Cargando…
Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease
Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The dia...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
the Society for Free Radical Research Japan
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127229/ https://www.ncbi.nlm.nih.gov/pubmed/18188413 http://dx.doi.org/10.3164/jcbn.40.116 |
_version_ | 1782141984871284736 |
---|---|
author | Kuriyama, Shoko Miwa, Yoshiyuki Fukushima, Hideki Nakamura, Hironori Toda, Katsuhisa Shiraki, Makoto Nagaki, Masahito Yamamoto, Mayumi Tomita, Eiichi Moriwaki, Hisataka |
author_facet | Kuriyama, Shoko Miwa, Yoshiyuki Fukushima, Hideki Nakamura, Hironori Toda, Katsuhisa Shiraki, Makoto Nagaki, Masahito Yamamoto, Mayumi Tomita, Eiichi Moriwaki, Hisataka |
author_sort | Kuriyama, Shoko |
collection | PubMed |
description | Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The diagnosis of diabetes was made with the criteria by World Health Organization. Laboratory investigation included serum asparate aminotransferase, alanine aminotransferase, albumin, fasting blood sugar, hemoglobin A1c (HbA1c), fasting immunoreactive insulin, and HOMA-R (FBS*IRI/405). The incidence of macro- and microangiopathy were also examined. Forty (17.5%) CLD patients were diagnosed diabetes, giving a significantly higher incidence than that of general cohort (5.3%) (p<0.001). Among them, 12 (30%) had the triopathy, significantly lower than that in a matched group of diabetic patients without CLD (65%) (p<0.001). Significantly increased levels of HbA1c and HOMA-R were observed in diabetic CLD with angiopathy compared with diabetic CLD without. Incidence of diabetes was increased in viral CLD patients. The rate of diabetic angiopathies in CLD, however, was relatively low, this could be explained by low coagulability in these patients. Poor control of hyperglycemia, partly due to insulin resistance, might explain the onset of angiopathy in diabetic CLD. |
format | Text |
id | pubmed-2127229 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2007 |
publisher | the Society for Free Radical Research Japan |
record_format | MEDLINE/PubMed |
spelling | pubmed-21272292008-01-09 Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease Kuriyama, Shoko Miwa, Yoshiyuki Fukushima, Hideki Nakamura, Hironori Toda, Katsuhisa Shiraki, Makoto Nagaki, Masahito Yamamoto, Mayumi Tomita, Eiichi Moriwaki, Hisataka J Clin Biochem Nutr Original Article Patients with chronic liver disease (CLD) often develops glucose intolerance. We explored the prevalence of diabetes mellitus in viral CLD, and analyzed factors profoundly affecting the diabetic angiopathies. 229 CLD patients (124 chronic hepatitis and 105 liver cirrhosis) entered the study. The diagnosis of diabetes was made with the criteria by World Health Organization. Laboratory investigation included serum asparate aminotransferase, alanine aminotransferase, albumin, fasting blood sugar, hemoglobin A1c (HbA1c), fasting immunoreactive insulin, and HOMA-R (FBS*IRI/405). The incidence of macro- and microangiopathy were also examined. Forty (17.5%) CLD patients were diagnosed diabetes, giving a significantly higher incidence than that of general cohort (5.3%) (p<0.001). Among them, 12 (30%) had the triopathy, significantly lower than that in a matched group of diabetic patients without CLD (65%) (p<0.001). Significantly increased levels of HbA1c and HOMA-R were observed in diabetic CLD with angiopathy compared with diabetic CLD without. Incidence of diabetes was increased in viral CLD patients. The rate of diabetic angiopathies in CLD, however, was relatively low, this could be explained by low coagulability in these patients. Poor control of hyperglycemia, partly due to insulin resistance, might explain the onset of angiopathy in diabetic CLD. the Society for Free Radical Research Japan 2007-03 2007-03-14 /pmc/articles/PMC2127229/ /pubmed/18188413 http://dx.doi.org/10.3164/jcbn.40.116 Text en Copyright © 2007 JCBN This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Kuriyama, Shoko Miwa, Yoshiyuki Fukushima, Hideki Nakamura, Hironori Toda, Katsuhisa Shiraki, Makoto Nagaki, Masahito Yamamoto, Mayumi Tomita, Eiichi Moriwaki, Hisataka Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease |
title | Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease |
title_full | Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease |
title_fullStr | Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease |
title_full_unstemmed | Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease |
title_short | Prevalence of Diabetes and Incidence of Angiopathy in Patients with Chronic Viral Liver Disease |
title_sort | prevalence of diabetes and incidence of angiopathy in patients with chronic viral liver disease |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2127229/ https://www.ncbi.nlm.nih.gov/pubmed/18188413 http://dx.doi.org/10.3164/jcbn.40.116 |
work_keys_str_mv | AT kuriyamashoko prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT miwayoshiyuki prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT fukushimahideki prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT nakamurahironori prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT todakatsuhisa prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT shirakimakoto prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT nagakimasahito prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT yamamotomayumi prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT tomitaeiichi prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease AT moriwakihisataka prevalenceofdiabetesandincidenceofangiopathyinpatientswithchronicviralliverdisease |